Brand
Slate Run Pharmaceuticals recalls
3 federal recalls on file, showing the 1 from the last 12 months. We monitor every CPSC, FDA, USDA, and NHTSA notice for Slate Run Pharmaceuticals and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-03-04FDA-DrugClass IIICheck Slate Run Eptifibatide Injection labeling
Slate Run Pharmaceuticals is recalling Eptifibatide Injection 75 mg/100 mL vials because the carton label says "weight-adjusted bolus dosing" when it should say "weight-adjusted infusion." This labeling error could lead to incorrect administration of the medication. No injuries have been reported.
Get the week's recalls, including Slate Run Pharmaceuticals
Free weekly digest — every federal recall affecting your household, Slate Run Pharmaceuticals included when it comes up. Track Slate Run Pharmaceuticals specifically with Always-on.
Explore other recall topics
By hazard
By state
Get alerts for your household